Review
Review of theoretical passive drug absorption models: Historical background, recent developments and limitations

https://doi.org/10.1016/S0031-6865(96)00031-3Get rights and content

Abstract

In the drug discovery process the optimization of a promising lead to an orally bioavailable drug remains a difficult task. Recent progress in the understanding of the role of physicochemical properties in membrane permeability relevant to important processes such as drug absorption and blood-brain barrier crossing, brings rational drug delivery more within reach. In the last thirty years a number of theoretical transport and absorption models have been developed to describe mathematically how a drug is being passively transported from its site of administration to its site of action and how a compound passes a membrane. The goal of such models is to rationalize the physical significance of the observed non-linear structure-permeability relationships. The models are based on various views on the composition of the biological membranes and on the underlying diffusion and distribution mechanisms. Often simplifications reducing the mathematical complexity are made. We review here a selection of the most important models and discuss modern views on the role of lipophilicity and various pathways through membranes.

References (115)

  • R.J. Scheuplein

    Analysis of permeability data for the case of parallel diffusion pathway

    Biophys. J.

    (1966)
  • R.N. Smith et al.

    Selection of a reference partitioning system for drug design work

    J. Pharm. Sci.

    (1975)
  • R.G. Stehle et al.

    Diffusional model for transport rate studies across membranes

    J. Pharm. Sci.

    (1967)
  • R.G. Stehle et al.

    In vitro model for transport of solutes in three-phase system I: Theoretical principles

    J. Pharm. Sci.

    (1972)
  • A. Suzuki et al.

    Theoretical studies of drug absorption and transport in the gastro intestinal tract I

    J. Pharm. Sci.

    (1970)
  • A. Suzuki et al.

    Theoretical studies of drug absorption and transport in the gastro intestinal tract II

    J. Pharm. Sci.

    (1970)
  • M.H. Abraham et al.

    The factors that influence skin penetration of solutes

    J. Pharm. Pharmacol.

    (1995)
  • P. Artursson

    Cell culures as models for drug absorption across the intestinal mucosa

    Crit. Rev. Ther. Drug Carrier Syst.

    (1991)
  • A. Avdeef

    Assessment of distribution-pH profiles

  • A.H. Beckett et al.

    The influence of alkylsubstitution in acids on their performance in the buccal absorption test

    J. Pharm. Pharmacol.

    (1968)
  • J.A. Blair et al.

    Acidification in the rat proximal jejenum

    J. Physiol.

    (1975)
  • E. Brunner

    Reaktionsgeschwindigkeit in heterogenen Systemen

    Z. Phys. Chem.

    (1904)
  • A.L. Bunge et al.

    A new method for estimating dermal absorption from chemical exposure: 2. Effect of molecular weight and octanol-water partitioning

    Pharm. Res.

    (1995)
  • P.S. Burton et al.

    The influence of molecular volume and hydrogen-bonding on peptide transport across epithelial membranes

    Pharm. Res.

    (1993)
  • R. Collander

    The distribution of organic copounds between iso-octanol and water

    Acta Chem. Scand.

    (1950)
  • R. Collander

    The partition of organic compounds between higher alcohols and water

    Acta Chem. Scand.

    (1951)
  • R.A. Conradi et al.

    Physicochemical and biological factors that influence a drug's cellular permeability by passive diffusion

  • F.H.N. De Haan et al.

    Rationally designed model with general applicability for absorption by passive diffusion

  • F.H.N. De Haan

    Development and application of model-based relationships describing ‘in vivo’ absorption kinetics

  • N. El Tayar et al.

    Polar intermolecular interactions encoded in partition coefficients: An indirect estimation of hydrogen-bonding parameters of polyfunctional solutes

    J. Phys. Chem.

    (1992)
  • G.L. Flynn et al.

    Mass transport phenomena and models: Theoretical concepts

    J. Pharm. Sci.

    (1974)
  • W. Forth et al.
  • T. Fujita et al.

    A new substituent constant, π, derived from partition coefficients

    J. Am. Chem. Soc.

    (1964)
  • T. Fujita et al.

    Hydrogen-bonding parameter and its significance in quantitative structure-activity studies

    J. Med. Chem.

    (1977)
  • C. Hansch

    A quantitative approach to biochemical structure-activity relationships

    Accounts Chem. Res.

    (1969)
  • C. Hansch

    Quantitative structure-activity relationships in drug design

  • W.L. Hayton

    Rate-limiting barriers to intestinal drug absorption: A review

    J. Pharmacokin. Biopharm.

    (1980)
  • W.I. Higuchi et al.

    Rate limiting steps and factors in drug absoption

  • M. Hildebrand

    Pharmakokinetik und Arzneimittelentwicklung

    Deutsche Apotheker Z.

    (1994)
  • A.R. Hilgers et al.

    Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa

    Pharm. Res.

    (1990)
  • A.P. Hill et al.

    Oral delivery of 5-HT1D receptor agonists: Towards the discovery of 311C90, a novel anti-migraine agent

    Headache

    (1994)
  • N.F.H. Ho et al.

    Physical model approach to the design of drugs with improved intestinal absorption

  • N.F.H. Ho et al.

    Advancing quantitative and mechanistic approaches in interfacing gastrointestinal drug absorption studies in animals and man

  • C.A.M. Hogben et al.

    On the mechanism of intestinal absorption of drugs

    J. Pharm. Exp. Ther.

    (1959)
  • J.B. Houston et al.

    A reevaluation of the importance of partition coefficients in the gastro-intestinal absorption of anutrients

    J. Pharmacol. Exp. Ther.

    (1974)
  • J. Hunter et al.

    Drug absorption limited by P-glycoprotein- mediated secretory drug transport in human intestinal epithelial Caco-2 cell layers

    Pharm. Res.

    (1993)
  • R.M. Hyde et al.

    A comparision of two related approaches to modelling in QSAR

    Eur. J. Med. Chem.

    (1979)
  • K. Kakemi et al.

    Absorption and excretion of drugs. XXX. On the mechanisms of rectal absorption of sulfonamides

    Chem. Pharm. Bull.

    (1965)
  • K. Kakemi et al.

    Absorption and excretion of drugs: XXX. Absorption of barbituric acid derivates from rat stomach

    Chem. Pharm. Bull.

    (1967)
  • K. Kakemi et al.

    Absorption and excretion of drugs. XXXII. Absorption of barbituric acid derivates from rat small intestine

    Chem. Pharm. Bull.

    (1967)
  • Cited by (151)

    • Revisiting the distribution/permeability regularities exemplified by cationic drug amitriptyline hydrochloride: Impact of temperature and pH

      2022, Journal of Molecular Liquids
      Citation Excerpt :

      Table S2 represents the mole fraction experimental concentrations in the organic and aqueous phases, as well as the distribution coefficients derived from mole fractions in all the studied systems at 6 temperatures. The distribution coefficient of the substance is ruled by several factors, among them the molecular size, dipole–dipole, ion-ion interaction, hydrogen bonding and possible solute–solvent interactions [17]. The transferring thermodynamic functions from aqueous to organic phase, practically useful for industrial optimization of the extraction processes through temperature manipulations, were calculated in this study in order to disclose the driving forces of the processes in the frameworks of solute–solvent interactions.

    • Insight into the uptake and metabolism of a new insecticide cyetpyrafen in plants

      2022, Environment International
      Citation Excerpt :

      The results indicated that the root uptake of cyetpyrafen was possibly through a passive diffusion process, in which aquaporin and anion channels might not participate (Yu et al., 2021). The passive diffusion of organic compounds mainly relies on three interdependent properties: lipophilicity, polarity and molecular size/weight (Camenisch et al., 1998; Camenisch et al., 1996; Tommasini et al., 1998). Lipophilic xenobiotics with net neutral charge and molecular weight lower than 450 g/mol are supposed to cross lipid bilayers by passive diffusion (Kumar and Gupta, 2016; Sterling, 1994; Trapp and Mcfarlane, 1995).

    • Administration of phytochemical nanoformulations (main routes of drug delivery)

      2022, Phytochemical Nanodelivery Systems as Potential Biopharmaceuticals
    • Modeling the interaction of amphiphilic polymer nanoparticles with biomembranes to Guide rational design of drug delivery systems

      2020, Colloids and Surfaces B: Biointerfaces
      Citation Excerpt :

      For traditional drugs to reach a therapeutic site within the cell, most drug molecules take advantage of a mechanism of passive diffusion through the membrane. Such a process is limited to low molecular weight, mostly amphiphilic molecules [9–12], thus excluding larger, possibly more effective and safer molecules. Different nanoparticles have been shown to enter the cell through endocytosis.

    View all citing articles on Scopus
    View full text